Investment - Narrative (Details) $ in Millions	Mar. 06, 2020 USD ($)
Delix Therapeutics, Inc.
Schedule of Equity Method Investments [Line Items]
Ownership percentage in Delix Therapeutics, Inc (in percent)	8.00%
Delix Therapeutics, Inc.
Schedule of Equity Method Investments [Line Items]
Purchase of investments	$ 0.5

The cash outflow associated with the purchase of all investments (debt, security, other) during the period.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585

Name:	us-gaap_PaymentsToAcquireInvestments
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration